ARIAD Pharmaceuticals

Annaly Capital Management, GNC Holdings and Southern Copper are among the companies that have seen insider buying recently. Insiders may sell shares for any number of reasons, but conventional wisdom says that insiders really only buy shares of a company for one reason -- they believe the stock...

Here's a look at the top tickers trending on StockTwits.com BlackBerry: Is the turnaround on track? BlackBerry (NASDAQ: BBRY) revealed its first Foxconn manufactured smartphone, the BlackBerry Z3. According to Techcrunch.com the phone is “a Nokia-like touchscreen smartphone with rounded sides, a...

Shares of the following exchange traded funds are trading more than 20 percent higher than 90 days ago, and they are within 10 percent of their 52-week highs. This set of ETFs provides a peek at areas of investor interest during and after the holiday shopping season, as uncertainty over the...

Stocks traded mostly lower today as investors digested a new set of earnings that were disappointing. A mixed housing data and a consumer sentiment coming in lower than expected was enough to tame the bulls as major indices finished the day mixed. Markets will be closed on Monday for Martin...

Here's a look at the top tickers trending on StockTwits.com. Ariad Pharmaceuticals On Friday morning, Ariad Pharmaceuticals (NASDAQ: ARIA) announced the commercial availability of Iclusig for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive acute...

Monday's trading session featured a plethora of analyst upgrades and downgrades. With little key economic data released, markets were relatively tame as major indices failing to meaningfully move in any one direction. The Senate appears to be set to officially Janet Yellen to lead the Federal...

Major indices saw plenty of red during the first trading session of 2014. There were no fundamental reasons for the Dow to suffer a triple digit point loss, along with the S&P 500 and Nasdaq indices ending the day lower. "People are taking profits and seeking bargains," according to Jim...

Major indices received a boost in Friday's trading activity following a better than expected third quarter GDP. The surprising economic data is yet another key data that may suggests that the economy is healthy enough and could handle the Fed's recent decision to taper its bond buying program....

According to Jim Bullard, the chances of the Fed tapering have increased due to recent labor market data. “There is no widely accepted reason why inflation is running as low as it is in the face of extraordinarily accommodative policy for the Fed,” he added. The St. Louis Fed chief added that...

The Nasdaq index traded above 4,000 for the first time since 2000. The other major indices were flat for the day as markets couldn't hold on to early gains that were boosted by an international accord with Iran. Economic news was rather light and there were no comments from a Fed chairperson that...

While not offering any specifics, investors seemed comfortable enough with Dennis Lockhart's comments to end the week on a positive note. While speaking to CNBC the Atlanta Fed chief commented that tapering will begin “when the economy is ready and when the market is ready.” Lockhart also noted...

Here is a quick look at three top-performing biotech stocks, each with a consensus recommendation (among analysts) of Strong Buy. They are Ariad Pharmaceuticals (NASDAQ: ARIA), Merrimack Pharmaceuticals (NASDAQ: MACK) and Synageva BioPharma (NASDAQ: GEVA). Ariad Pharmaceuticals Shares of this...